Philip Morris Stock Price, News & Analysis

Philip Morris International (NYSE: PM) reaffirmed its 2025 full-year forecast during the Barclays Global Consumer Staples Conference. The company expects reported diluted EPS of $7.24 to $7.37 and adjusted diluted EPS of $7.43 to $7.56, representing growth of 13% to 15% (11.5% to 13.5% excluding currency).

PMI reported strong Q3-to-date performance, highlighting accelerated ZYN growth to 32% in the first 8 weeks of Q3, robust IQOS momentum, and better-than-expected combustible volume recovery in Turkey and Egypt. The company's smoke-free products are now available in 97 markets, used by over 41 million consumers, and accounted for 41% of first-half 2025 total net revenues.

Since 2008, PMI has invested over $14 billion in smoke-free product development, aiming to completely end cigarette sales and expand into wellness and healthcare areas.

Philip Morris International (NYSE: PM) announced it will host a fireside chat session at the 2025 Barclays Global Consumer Staples Conference. CEO Jacek Olczak will lead the session on September 2, 2025, at 11:15 a.m. ET, with a live webcast available at pmi.com/2025barclays.

The company provided key business updates, highlighting that its smoke-free products are now available in 97 markets with approximately 41 million users globally. The smoke-free segment contributed 41% of PMI's first-half 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing and commercializing smoke-free products, demonstrating its commitment to a smoke-free future.

Philip Morris International (NYSE: PM) reported strong Q2 2025 results, with reported diluted EPS growing 26.6% to $1.95 and adjusted diluted EPS increasing 20.1% to $1.91. The company's smoke-free business now accounts for 41% of total net revenues, up 2.9 percentage points year-over-year.

Key highlights include IQOS exceeding $3 billion in quarterly net revenues, ZYN's U.S. offtake growth reaccelerating to 36% in June, and smoke-free product shipment volumes increasing by 11.8%. The company raised its full-year 2025 guidance, now projecting adjusted diluted EPS of $7.43-$7.56, representing 13-15% growth.

Total net revenues reached $10.1 billion, up 7.1% year-over-year, while operating income grew 7.8% to $3.7 billion. The company's smoke-free products are now available in 97 markets, with IQOS maintaining approximately 76% global heat-not-burn category share.

Philip Morris International (NYSE: PM) has announced it will host a live audio webcast to discuss its 2025 second-quarter and first-half results on Tuesday, July 22, 2025, at 9:00 a.m. ET. The results will be released at approximately 7:00 a.m. ET the same day.

The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products, with FDA authorizations for IQOS devices, General snus, and ZYN nicotine pouches.

Philip Morris International (NYSE: PM) has declared a regular quarterly dividend of $1.35 per common share, payable on July 15, 2025, to shareholders of record as of June 27, 2025. PMI continues to advance its smoke-free future strategy, with smoke-free products now available in 95 markets and used by 38.6 million adults globally. The company's smoke-free business represented 42% of total net revenues in Q1 2025, supported by over $14 billion in investments since 2008. PMI's portfolio includes FDA-authorized products like Swedish Match's General snus, ZYN nicotine pouches, and IQOS devices, while the company aims to expand into wellness and healthcare sectors.

According to a KPMG study, illicit cigarette consumption in the European Union reached 38.9 billion units in 2024, marking a 10.8% increase from 2023 and the highest level since 2015. France emerged as Europe's largest illicit market with 18.7 billion illicit cigarettes (37.6% of total consumption), while the Netherlands saw its illicit share double to 17.9%. The illegal trade cost EU governments €14.9 billion in lost tax revenues. Counterfeit cigarettes increased by 20.2% to 15.3 billion units, while illicit whites reached 8.2 billion. Some countries showed improvement, with Greece and Ukraine recording 30% declines in illicit consumption. PMI urges for evidence-based regulation, predictable tax regimes, and enhanced law enforcement to combat this growing threat.

Philip Morris International (NYSE: PM) reaffirmed its 2025 full-year forecast during the dbAccess Global Consumer Conference. The company expects reported diluted EPS of $7.01-$7.14 and adjusted diluted EPS of $7.36-$7.49, representing growth of 12-14% (10.5-12.5% excluding currency). PMI's smoke-free products are now available in 95 markets, with 38.6 million adult users, contributing 42% of Q1 2025 total net revenues. The company has invested over $14 billion since 2008 in developing smoke-free alternatives, receiving FDA authorizations for IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches. PMI aims to expand into wellness and healthcare areas while maintaining its smoke-free transformation strategy.

Philip Morris International (NYSE: PM) has announced it will host a live webcast of its presentation at the 2025 dbAccess Global Consumer Conference. The session will feature CFO Emmanuel Babeau on June 3, 2025, at 11:15 a.m. CET. The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing smoke-free products, demonstrating its commitment to a smoke-free future. The company has received FDA authorizations for its IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches.

Philip Morris International (NYSE: PM) held its 2025 Annual Meeting of Shareholders, highlighting significant achievements in its smoke-free transformation. CEO Jacek Olczak reported that the company's smoke-free business reached nearly $15 billion in net revenues, with smoke-free products accounting for 42% of PMI's Q1 2025 total net revenues.

The company's leading brands IQOS and ZYN marked their 10-year anniversaries in 2024. As of December 31, 2024, PMI's smoke-free products were available in 95 markets and used by 38.6 million adults globally. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products. The meeting saw approximately 82% shareholder participation, with shareholders electing 11 directors and approving executive compensation and auditor selection.